Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases von Katz, Steven C, Burga, Rachel A, McCormack, Elise, Wang, Li Juan, Mooring, Wesley, Point, Gary R, Khare, Pranay D, Thorn, Mitchell, Ma, Qiangzhong, Stainken, Brian F, Assanah, Earle O, Davies, Robin, Espat, N Joseph, Junghans, Richard P

Volltext

Neutrophil:lymphocyte ratios and serum cytokine changes after hepatic artery chimeric antigen receptor-modified T-cell infusions for liver metastases von Saied, A, Licata, L, Burga, R A, Thorn, M, McCormack, E, Stainken, B F, Assanah, E O, Khare, P D, Davies, R, Espat, N J, Junghans, R P, Katz, S C

Volltext